NewslettersMammary Cell News Targeting of Mcl-1 in Breast Cancer-Associated Fibroblasts Reverses Their Myofibroblastic Phenotype and Pro-Invasive Properties By Bob - September 22, 2022 0 Scientists showed that pharmacological inhibition or knock down of MCL-1 in primary breast ancer-associated fibroblasts directly derived from human samples mitigated myofibroblastic features. [Cell Death & Disease] Full Article